Funding for this research was provided by:
Adapt Pharma (52305A)
New Mexico State Targeted Response Initiative (SubAward contract from New Mexico Behavioral Health Services Division)
Received: 30 January 2020
Accepted: 28 April 2020
First Online: 13 May 2020
Ethics approval and consent to participate
: This research was approved by the University of New Mexico Human Research Protections Office, HRPO #18-573.
: Not Applicable
: The authors declare that they have no competing interests.